JP2011500600A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500600A5
JP2011500600A5 JP2010529094A JP2010529094A JP2011500600A5 JP 2011500600 A5 JP2011500600 A5 JP 2011500600A5 JP 2010529094 A JP2010529094 A JP 2010529094A JP 2010529094 A JP2010529094 A JP 2010529094A JP 2011500600 A5 JP2011500600 A5 JP 2011500600A5
Authority
JP
Japan
Prior art keywords
ring
benzamide
cor
sulfonyl
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010529094A
Other languages
English (en)
Japanese (ja)
Other versions
JP5562859B2 (ja
JP2011500600A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079546 external-priority patent/WO2009049183A1/en
Publication of JP2011500600A publication Critical patent/JP2011500600A/ja
Publication of JP2011500600A5 publication Critical patent/JP2011500600A5/ja
Application granted granted Critical
Publication of JP5562859B2 publication Critical patent/JP5562859B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010529094A 2007-10-11 2008-10-10 電位開口型ナトリウムチャネルの阻害剤として有用なアリールアミド Expired - Fee Related JP5562859B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97928907P 2007-10-11 2007-10-11
US60/979,289 2007-10-11
PCT/US2008/079546 WO2009049183A1 (en) 2007-10-11 2008-10-10 Aryl amides useful as inhibitors of voltage-gated sodium channels

Publications (3)

Publication Number Publication Date
JP2011500600A JP2011500600A (ja) 2011-01-06
JP2011500600A5 true JP2011500600A5 (https=) 2012-11-15
JP5562859B2 JP5562859B2 (ja) 2014-07-30

Family

ID=40373086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010529094A Expired - Fee Related JP5562859B2 (ja) 2007-10-11 2008-10-10 電位開口型ナトリウムチャネルの阻害剤として有用なアリールアミド

Country Status (13)

Country Link
US (1) US8779197B2 (https=)
EP (1) EP2212290B1 (https=)
JP (1) JP5562859B2 (https=)
KR (1) KR20100075631A (https=)
CN (1) CN101883758A (https=)
AU (1) AU2008310663A1 (https=)
CA (1) CA2702101A1 (https=)
IL (1) IL204978A0 (https=)
MX (1) MX2010003865A (https=)
NZ (1) NZ584519A (https=)
RU (1) RU2010118467A (https=)
WO (1) WO2009049183A1 (https=)
ZA (1) ZA201002604B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014212431B2 (en) * 2013-01-31 2018-04-05 Vertex Pharmaceuticals Incorporated Amides as modulators of sodium channels
CN105073738B (zh) * 2013-01-31 2018-01-05 沃泰克斯药物股份有限公司 作为钠通道调节剂的喹啉及喹喔啉酰胺类
KR102295748B1 (ko) 2013-01-31 2021-09-01 버텍스 파마슈티칼스 인코포레이티드 나트륨 채널의 조절제로서의 피리돈 아미드
ES2654393T3 (es) 2013-07-19 2018-02-13 Vertex Pharmaceuticals Incorporated Sulfonamidas como moduladores de los canales de sodio
LT3080134T (lt) 2013-12-13 2018-11-12 Vertex Pharmaceuticals Incorporated Piridono amidų provaistai, naudotini kaip natrio kanalų moduliatoriai
EP3359151A4 (en) * 2015-10-07 2019-08-14 Arizona Board of Regents on behalf of the University of Arizona CRMP2 SUMOYLATION INHIBITORS AND USES THEREOF
US11358977B2 (en) 2017-05-16 2022-06-14 Vertex Pharmaceuticals Incorporated Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
SG11202000230VA (en) 2017-07-11 2020-02-27 Vertex Pharma Carboxamides as modulators of sodium channels
WO2019157505A1 (en) 2018-02-12 2019-08-15 Vertex Pharmaceuticals Incorporated A method of treating pain
AU2019302534B2 (en) 2018-07-09 2024-10-03 Lieber Institute, Inc. Pyridazine compounds for inhibiting NaV1.8
AU2019301628C1 (en) * 2018-07-09 2025-02-06 Lieber Institute, Inc. Pyridine carboxamide compounds for inhibiting NaV1.8
WO2020092187A1 (en) 2018-11-02 2020-05-07 Merck Sharp & Dohme Corp. 2-amino-n-phenyl-nicotinamides as nav1.8 inhibitors
EP3873893A1 (en) 2018-11-02 2021-09-08 Merck Sharp & Dohme Corp. 2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors
CA3125244A1 (en) * 2019-01-04 2020-07-09 Jiangsu Hengrui Medicine Co., Ltd. 6-oxo-1,6-dihydropyridazine derivative, preparation method therefor and medical use thereof
US12441703B2 (en) 2019-01-10 2025-10-14 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
WO2020146612A1 (en) * 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
CN112996776B (zh) * 2019-02-20 2024-03-15 福建盛迪医药有限公司 6-氧代-1,6-二氢哒嗪类前药衍生物、其制备方法及其在医药上的应用
CN112390745B (zh) * 2019-08-19 2022-10-21 江苏恒瑞医药股份有限公司 吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用
GEP20247688B (en) * 2019-09-12 2024-11-11 Orion Corp Pyridine oxynitride, preparation method therefor and use thereof
CA3164134A1 (en) 2019-12-06 2021-06-10 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
CN114437062B (zh) * 2020-04-30 2024-05-17 成都海博为药业有限公司 一种可作为钠通道调节剂的化合物及其用途
JP2023530319A (ja) 2020-06-17 2023-07-14 メルク・シャープ・アンド・ドーム・エルエルシー Nav1.8阻害剤としての2-オキソ-オキサゾリジン-5-カルボキサミド
GEP20257750B (en) 2020-06-17 2025-03-25 Merck Sharp & Dohme Llc 2-oxoimidazolidine-4-carboxamides as nav1.8 inhibitors
CN114031518B (zh) * 2020-12-08 2023-08-18 成都海博为药业有限公司 一种苄胺或苄醇衍生物及其用途
EP4334293A1 (en) 2021-05-07 2024-03-13 Merck Sharp & Dohme LLC Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitors
SI4347031T1 (sl) 2021-06-04 2026-01-30 Vertex Pharmaceuticals Incorporated N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
TW202317520A (zh) 2021-06-15 2023-05-01 德商歌林達有限公司 經取代之吡唑醯胺
UY40234A (es) 2022-04-22 2023-11-15 Vertex Pharma Compuestos heteroarilo para el tratamiento del dolor
CN119894509A (zh) * 2022-09-09 2025-04-25 拉堤果生物医疗股份有限公司 钠通道阻断化合物、其衍生物和其使用方法
EP4385984A1 (en) 2022-12-14 2024-06-19 Grünenthal GmbH Pyridine-n-oxides as inhibitors of nav1.8
EP4385980A1 (en) 2022-12-14 2024-06-19 Grünenthal GmbH Indazoles as inhibitors of nav1.8
EP4385979A1 (en) 2022-12-14 2024-06-19 Grünenthal GmbH Multicyclic inhibitors of nav1.8
AR131345A1 (es) 2022-12-14 2025-03-12 Gruenenthal Gmbh SULFOXIMINAS COMO INHIBIDORES DE NaV1.8

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE568114A (https=) 1957-05-29 1900-01-01
ES482591A1 (es) 1978-07-20 1980-04-01 Basf Ag Procedimiento para la obtencion de n-arilsulfonilpirroles.
PE20010306A1 (es) * 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
US6620849B2 (en) * 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
AU2002363250A1 (en) 2001-11-01 2003-05-12 Icagen, Inc. Pyrazole-amides and-sulfonamides
SE0203752D0 (sv) 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
WO2004106324A1 (en) 2003-05-27 2004-12-09 E.I. Dupont De Nemours And Company Azolecarboxamide herbicides
US8202861B2 (en) * 2003-08-08 2012-06-19 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of voltage-gated sodium channels
EP1819341A4 (en) 2004-11-10 2011-06-29 Synta Pharmaceuticals Corp IL-12 MODULATORY CONNECTIONS
AU2006260299B8 (en) * 2005-06-21 2012-11-29 Mitsui Chemicals, Inc. Amide derivative and insecticide containing the same
PE20110118A1 (es) 2005-10-04 2011-03-08 Aventis Pharma Inc Compuestos de pirimidina amida como inhibidores de pgds
CA2648202A1 (en) * 2006-04-11 2007-10-25 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of voltage-gated sodium channels

Similar Documents

Publication Publication Date Title
JP2011500600A5 (https=)
RU2010118467A (ru) Ариламиды, пригодные в качестве ингибиторов потенциалзависимых натриевых каналов
JP2011500599A5 (https=)
KR101235961B1 (ko) 프로스타글란딘 d2 수용체의 n,n-이치환 아미노알킬비페닐 길항제
JP2022050538A (ja) プロスタサイクリン(pgi2)受容体に関連する障害の処置に有用なpgi2受容体の調節因子
RU2008144415A (ru) Композиции, полезные в качестве ингибиторов потенциалзависимых натриевых каналов
RU2010118481A (ru) Амиды, применимые в качестве ингибиторов потенциалзависимых натриевых каналов
JP2020526561A5 (https=)
EP2245022A2 (en) Antagonists of prostaglandin d2 receptors
AU2019226215A1 (en) Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
JP2011512359A (ja) プロスタグランジンd2受容体のアンタゴニストとしての環式ジアリールエーテル化合物
ES2232114T3 (es) Derivados de cicloalqueno, procedimiento para su produccion, y uso.
JP2011518130A (ja) プロスタグランジンd2受容体のアミノアルキルフェニルアンタゴニスト
JP2012515166A5 (https=)
JP5342451B2 (ja) Pde4阻害剤として有用な置換アセトフェノン
CN1474818A (zh) 含有稠合杂环化合物或其盐的糖尿病预防或治疗药
JP2016500661A5 (https=)
GB2461629A (en) Phenoxy acetic acids as atagonists of prostaglandin D2 receptors
JP2014500330A5 (https=)
CN1361763A (zh) 作为IL-1β和TNF-α的抑制剂的氨基二苯酮
RU2247719C2 (ru) Аминобензофеноны как ингибиторы il-1 бета и tnf-альфа, фармацевтическая композиция и способ лечения и/или профилактики воспалительных заболеваний
JP2006515319A (ja) Taceのインヒビター
JPWO2020243488A5 (https=)
CN103384522B (zh) 咖啡酸衍生物和它们在改善神经细胞生存力中的用途
US10391076B2 (en) Anti-cancer agent comprising aminoacetonitrile compound as active ingredient